Insights |
Search OptionsInsightsThe Indiana General Assembly recently enacted significant new legislation that will impact both pharmacy benefit managers and health care providers doing business in Indiana
Regulation of Pharmacy Benefit Managers Take Five: 5 Things You Need to Know About Indiana Government - June 2025
1. Legislative Council assigns study committee topics The Indiana General Assembly’s Legislative Council convened on Thursday to announce topics that will be considered by interim study committees over the next several months. “Interim study… With SEA 140, Indiana Joins Other States in Limiting Pharmacy Benefit Manager Vertical Integration
Indiana recently enacted Senate Enrolled Act 140 (SEA 140), a significant overhaul of pharmacy reimbursement practices intended to greatly impact pharmacy benefit manager (“PBM”) vertical integration. SEA 140 introduces multiple changes to how… New Indiana Law Requires Disclosure of Appointed Officers
Beginning July 1, 2025, House Enrolled Act 1509 (codified at IC 5-14-9) takes effect in the State of Indiana and imposes mandatory disclosure requirements for appointed officers serving on any board, body, committee, commission or other… A Fair Shake: Ames Shifts Risk Landscape for Employers in Title VII Discrimination Claims
Employers across all industries should take note of a recent unanimous U.S. Supreme Court decision that stands to impact workplace discrimination claims and risk management strategies. The Court’s ruling in Ames v. Ohio Department of Youth Services… Tax-Exempt Status and Political Activity – Is Harvard Challenge a Concern for Your Organization?
Tax-exempt organizations of nearly every ilk must monitor recent activities targeting Harvard University to determine if those actions call for a reassessment and possibly redesign of operations and advocacy activities. While direct political… Avoid This Shortcut Despite the Temptation
Uniform Commercial Code (“UCC”) Section 9-504 reads as follows:
CFPB Withdraws 67 Guidance Documents
On May 9,2025, the Consumer Financial Protection Bureau (“CFPB”) filed a formal notice withdrawing 67 regulatory guidance documents in the Federal Register (here). The withdrawal of these various policy statements, interpretative rules, and advisory… The 340B Drug Pricing Playbook, with Brandon Shirley
Clients have asked Brandon Shirley about acquiring a health entity that would qualify for the 340B Drug Pricing Program because, as he explains, “it does enable substantial benefits if you can get into it.” But the program is also complex. A… The End of Physician Noncompetes in Indiana Hospitals: A Look into Indiana Senate Enrolled Act No. 475
In a significant development for healthcare employment law, Indiana’s Senate Enrolled Act No. 475 (“SEA 475”) broadens existing restrictions on physician noncompete agreements to include nearly all physician types—not just primary care providers.… Take Five: 2025 Legislative Session Wrap-Up
1. State Budget Early Friday morning, state lawmakers approved Indiana’s two-year budget- a task that was made much more difficult by the recent revenue forecast that predicted $2 billion less tax revenue over the biennium than was originally… Tele-prescribing Here to Stay? HHS Signals Commitment to COVID-19 Era Telemedicine Prescribing Expansions
After months of back and forth, with the fate of tele-prescribing in limbo, the Department of Health and Human Services (“HHS”) signaled its continued commitment to some COVID-19 era telemedicine expansions by the recent issuance of two final rules:… |
© 2025 Krieg DeVault LLP. All Rights Reserved.